TrialBrain imaging and behavior2021

Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia.

Michael M Francis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.